MANILA, Philippines — Anakalusugan Rep. Mike Defensor, an advocate of ivermectin, urged the Department of Health (DOH) and the Department of Science and Technology (DOST) to speed up clinical trials on the use of the controversial drug to treat COVID-19.
Defensor cited the urgency to address the pandemic in his call to hasten the clinical trials, adding that other drugs such as Remdesivir and Tocilizumab are “expensive” compared to ivermectin.
“Lives are at stake here. We could save many lives with the use of this popular P35-per-tablet experimental drug. The results of the trials ordered by President Duterte should be available soon,” Defensor said in a s…
Keep on reading: DOH, DOST urged: Speed up study on ivermectin use vs COVID-19